Mr Glenn Cross talked about the present and the future of commercialising and exporting Australian life sciences. He also shared valuable lessons and tips based on his life-long experience in the sector.

Approached by the State Government of Victoria, I had the pleasure to do medical interpreting for 24 Shanghai hospital presidents for their Melbourne visit. Have

On 29 August 2018, delegates from different sectors of medical and health gathered to listen to Rodney Hannington, Eagle Heath Non-Executive Director, for a keynote speech on “Insights into the Highly Dynamic Chinese

As another Australian Chinese healthcare commercialisation series, this time the Melbourne HealthCare Drinks event was held on Friday 23rd February, co-organised with ACASE.

On 8th October 2017, the Chinese government issued a ground-breaking policy to encourage innovation on review and approval of drugs and medical devices. On an expanded basis,

China Food and Drug Administration (CFDA) was approved as a new regulatory member of the ICH in May/ June 2017. Below we at Acurit Medical Communications translate and edit information

On 11 and 12 of May 2017, China Food and Drug Administration (FDA) announced on its official website four new draft regulations on drugs and medical devices. All drafts are currently inviting public comments.

The draft regulation was approved by CFDA on 20–Jun-2017 and published on 11-Oct-2017, under the title of No. 35 CFDA Degree. There are only minor revisions compared to the original statements.

In China, old-age dependency ratio will increase from the current 2.8:1 to 1.3:1 in 2050. On the other hand, the aged care industry still needs to be revitalised. Senile finance, supplies, services